Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viekira Pak in genotype 1 HCV with past PI failure
NCT02646111Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 3 trial of ombitasvir, paritaprevir, ritonavir, dasabuvir in Hepatitis C genotype 1, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
ombitasvirparitaprevirritonavirdasabuvir
03
Conditions
Hepatitis C genotype 1
Beyond the preview
Go deeper on NCT02646111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646111.